{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T03:18:59Z","timestamp":1771730339495,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T00:00:00Z","timestamp":1609891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81700271"],"award-info":[{"award-number":["81700271"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"S&T Program of Hebei","award":["H2018105054"],"award-info":[{"award-number":["H2018105054"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. of Cardiovasc. Trans. Res."],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s12265-020-10089-2","type":"journal-article","created":{"date-parts":[[2021,1,6]],"date-time":"2021-01-06T23:08:32Z","timestamp":1609974512000},"page":"636-646","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Lefty1 Ameliorates Post-infarction Fibrosis by Suppressing p-Smad2 and p-ERK1\/2 Signaling Pathways"],"prefix":"10.1007","volume":"14","author":[{"given":"Chang-yi","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing-rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hui","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wan-ning","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Song-nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,1,6]]},"reference":[{"key":"10089_CR1","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00441-016-2431-9","volume":"365","author":"V Talman","year":"2016","unstructured":"Talman, V., & Ruskoaho, H. (2016). Cardiac fibrosis in myocardial infarction-from repair and remodeling to regeneration. Cell and Tissue Research, 365, 563\u2013581.","journal-title":"Cell and Tissue Research"},{"key":"10089_CR2","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.yjmcc.2010.10.033","volume":"51","author":"M Dobaczewski","year":"2011","unstructured":"Dobaczewski, M., Chen, W., & Frangogiannis, N. G. (2011). Transforming growth factor (TGF)-\u03b2 signaling in cardiac remodeling. Journal of Molecular and Cellular Cardiology, 51, 600\u2013606.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10089_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/37284","volume":"390","author":"CH Heldin","year":"1997","unstructured":"Heldin, C. H., Miyazono, K., & ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature, 390, 465\u2013471.","journal-title":"Nature"},{"key":"10089_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cardiores.2005.07.007","volume":"69","author":"G Euler-Taimor","year":"2006","unstructured":"Euler-Taimor, G., & Heger, J. (2006). The complex pattern of SMAD signaling in the cardiovascular system. Cardiovascular Research, 69, 15\u201325.","journal-title":"Cardiovascular Research"},{"key":"10089_CR5","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3892\/etm.2017.4246","volume":"13","author":"G Liu","year":"2017","unstructured":"Liu, G., Ma, C., Yang, H., & Zhang, P. Y. (2017). Transforming growth factor \u03b2 and its role in heart disease. Experimental and Therapeutic Medicine, 13, 2123\u20132128.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10089_CR6","doi-asserted-by":"crossref","unstructured":"Zhang, Y. E. (2017). Non-Smad signaling pathways of the TGF-\u03b2 family. Cold Spring Harbor Perspectives in Biology, 9, a022129.","DOI":"10.1101\/cshperspect.a022129"},{"key":"10089_CR7","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1086\/302289","volume":"64","author":"K Kosaki","year":"1999","unstructured":"Kosaki, K., Bassi, M. T., Kosaki, R., Lewin, M., Belmont, J., Schauer, G., & Casey, B. (1999). Characterization and mutation analysis of human LEFTY A and LEFTY B, homologues of murine genes implicated in left-right axis development. American Journal of Human Genetics, 64, 712\u2013721.","journal-title":"American Journal of Human Genetics"},{"key":"10089_CR8","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1074\/jbc.M108103200","volume":"277","author":"JM Mason","year":"2002","unstructured":"Mason, J. M., Xu, H. P., Rao, S. K., Leask, A., Barcia, M., Shan, J., Stephenson, R., & Tabibzadeh, S. (2002). Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mRNA expression and increased proteolytic activity in a fibrosarcoma model. The Journal of Biological Chemistry, 277, 407\u2013415.","journal-title":"The Journal of Biological Chemistry"},{"key":"10089_CR9","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3892\/mmr.2015.4631","volume":"13","author":"C Xu","year":"2016","unstructured":"Xu, C., Xu, M., Wang, W., & Zhang, J. (2016). Lefty1 alleviates renal tubulointerstitial injury in mice with unilateral ureteral obstruction. Molecular Medicine Reports, 13, 901\u2013908.","journal-title":"Molecular Medicine Reports"},{"key":"10089_CR10","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10735-020-09859-8","volume":"51","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Liu, X., Liang, J., Wu, J., Tan, D., & Hu, W. (2020). Lefty-1 inhibits renal epithelial-mesenchymal transition by antagonizing the TGF-\u03b2\/Smad signaling pathway. Journal of Molecular Histology, 51, 77\u201387.","journal-title":"Journal of Molecular Histology"},{"key":"10089_CR11","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s12964-017-0211-0","volume":"15","author":"W Fei","year":"2017","unstructured":"Fei, W., Kijima, D., Hashimoto, M., Hashimura, M., Oguri, Y., Kajita, S., Matsumoto, T., Yokoi, A., & Saegusa, M. (2017). A functional role of LEFTY during progesterone therapy for endometrial carcinoma. Cell Communication and Signaling: CCS, 15, 56.","journal-title":"Cell Communication and Signaling: CCS"},{"key":"10089_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.yjmcc.2017.02.002","volume":"105","author":"YH Chen","year":"2017","unstructured":"Chen, Y. H., Wang, Q., Li, C. Y., Hou, J. W., Chen, X. M., Zhou, Q., Chen, J., Wang, Y. P., & Li, Y. G. (2017). Haplodeficiency of activin receptor-like kinase 4 alleviates myocardial infarction-induced cardiac fibrosis and preserves cardiac function. Journal of Molecular and Cellular Cardiology, 105, 1\u201311.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10089_CR13","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1161\/CIRCRESAHA.118.313811","volume":"124","author":"L Ni","year":"2019","unstructured":"Ni, L., Scott Jr., L., Campbell, H. M., Pan, X., Alsina, K. M., Reynolds, J., Philippen, L. E., Hulsurkar, M., Lagor, W. R., Li, N., & Wehrens, X. H. T. (2019). Atrial-specific gene delivery using an adeno-associated viral vector. Circulation Research, 124, 256\u2013262.","journal-title":"Circulation Research"},{"key":"10089_CR14","doi-asserted-by":"crossref","unstructured":"Morikawa, M., Derynck, R., & Miyazono, K. (2016). TGF-\u03b2 and the TGF-\u03b2 family: context-dependent roles in cell and tissue physiology. Cold Spring Harbor Perspectives in Biology, 8,\u00a0a021873.","DOI":"10.1101\/cshperspect.a021873"},{"key":"10089_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.3389\/fcvm.2019.00140","volume":"6","author":"A Hanna","year":"2019","unstructured":"Hanna, A., & Frangogiannis, N. G. (2019). The role of the TGF-\u03b2 superfamily in myocardial infarction. Frontiers in Cardiovascular Medicine, 6, 140.","journal-title":"Frontiers in Cardiovascular Medicine"},{"key":"10089_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.ejphar.2016.07.053","volume":"789","author":"J Hu","year":"2016","unstructured":"Hu, J., Wang, X., Wei, S. M., Tang, Y. H., Zhou, Q., & Huang, C. X. (2016). Activin A stimulates the proliferation and differentiation of cardiac fibroblasts via the ERK1\/2 and p38-MAPK pathways. European Journal of Pharmacology, 789, 319\u2013327.","journal-title":"European Journal of Pharmacology"},{"key":"10089_CR17","first-page":"420","volume":"32","author":"JF Lin","year":"2016","unstructured":"Lin, J. F., Hsu, S. Y., Teng, M. S., Wu, S., Hsieh, C. A., Jang, S. J., Liu, C. J., Huang, H. L., & Ko, Y. L. (2016). Activin a predicts left ventricular remodeling and mortality in patients with ST-elevation myocardial infarction. Acta Cardiologica Sinica, 32, 420\u2013427.","journal-title":"Acta Cardiologica Sinica"},{"key":"10089_CR18","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1161\/HYPERTENSIONAHA.111.00562","volume":"61","author":"B Sun","year":"2013","unstructured":"Sun, B., Huo, R., Sheng, Y., Li, Y., Xie, X., Chen, C., Liu, H. B., Li, N., Li, C. B., Guo, W. T., Zhu, J. X., Yang, B. F., & Dong, D. L. (2013). Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy. Hypertension, 61, 352\u2013360.","journal-title":"Hypertension"},{"key":"10089_CR19","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/j.yjmcc.2010.01.010","volume":"48","author":"AS Pachori","year":"2010","unstructured":"Pachori, A. S., Custer, L., Hansen, D., Clapp, S., Kemppa, E., & Klingensmith, J. (2010). Bone morphogenetic protein 4 mediates myocardial ischemic injury through JNK-dependent signaling pathway. Journal of Molecular and Cellular Cardiology, 48, 1255\u20131265.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10089_CR20","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1093\/cvr\/cvw076","volume":"110","author":"D Merino","year":"2016","unstructured":"Merino, D., Villar, A. V., Garc\u00eda, R., Tramullas, M., Ruiz, L., Ribas, C., Cabezudo, S., Nistal, J. F., & Hurl\u00e9, M. A. (2016). BMP-7 attenuates left ventricular remodelling under pressure overload and facilitates reverse remodelling and functional recovery. Cardiovascular Research, 110, 331\u2013345.","journal-title":"Cardiovascular Research"},{"key":"10089_CR21","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/nm1613","volume":"13","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg, E. M., Tarnavski, O., Zeisberg, M., Dorfman, A. L., McMullen, J. R., Gustafsson, E., Chandraker, A., Yuan, X., Pu, W. T., Roberts, A. B., Neilson, E. G., Sayegh, M. H., Izumo, S., & Kalluri, R. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13, 952\u2013961.","journal-title":"Nature Medicine"},{"key":"10089_CR22","doi-asserted-by":"crossref","unstructured":"Ren, Q., Lin, P., Wang, Q., Zhang, B., & Feng, L. (2019). Chronic peripheral ghrelin injection exerts antifibrotic by increasing growth differentiation factor 15 in rat hearts with myocardial fibrosis induced by isoproterenol. Physiological Research, 69, 439\u2013450.","DOI":"10.33549\/physiolres.934183"},{"key":"10089_CR23","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/381151a0","volume":"381","author":"C Meno","year":"1996","unstructured":"Meno, C., Saijoh, Y., Fujii, H., Ikeda, M., Yokoyama, T., Yokoyama, M., Toyoda, Y., & Hamada, H. (1996). Left-right asymmetric expression of the TGF beta-family member lefty in mouse embryos. Nature, 381, 151\u2013155.","journal-title":"Nature"},{"key":"10089_CR24","doi-asserted-by":"publisher","first-page":"4669","DOI":"10.2147\/DDDT.S86770","volume":"9","author":"L Zhang","year":"2015","unstructured":"Zhang, L., Zhang, J., Xu, C., Zhou, X., Wang, W., Zheng, R., Hu, W., & Wu, P. (2015). Lefty-1 alleviates TGF-\u03b21-induced fibroblast-myofibroblast transdifferentiation in NRK-49F cells. Drug Design, Development and Therapy, 9, 4669\u20134678.","journal-title":"Drug Design, Development and Therapy"},{"key":"10089_CR25","doi-asserted-by":"publisher","first-page":"L741","DOI":"10.1152\/ajplung.00295.2016","volume":"312","author":"H Ma","year":"2017","unstructured":"Ma, H., Qiao, S., Wang, Z., Geng, S., Zhao, Y., Hou, X., Tian, W., Chen, X., & Yao, L. (2017). Microencapsulation of Lefty-secreting engineered cells for pulmonary fibrosis therapy in mice. American Journal of Physiology. Lung Cellular and Molecular Physiology, 312, L741\u2013l747.","journal-title":"American Journal of Physiology. Lung Cellular and Molecular Physiology"},{"key":"10089_CR26","doi-asserted-by":"publisher","first-page":"21397","DOI":"10.1074\/jbc.M010783200","volume":"276","author":"L Ulloa","year":"2001","unstructured":"Ulloa, L., & Tabibzadeh, S. (2001). Lefty inhibits receptor-regulated Smad phosphorylation induced by the activated transforming growth factor-beta receptor. The Journal of Biological Chemistry, 276, 21397\u201321404.","journal-title":"The Journal of Biological Chemistry"},{"key":"10089_CR27","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41419-020-2243-4","volume":"11","author":"L Gao","year":"2020","unstructured":"Gao, L., Wang, L. Y., Liu, Z. Q., Jiang, D., Wu, S. Y., Guo, Y. Q., Tao, H. M., Sun, M., You, L. N., Qin, S., Cheng, X. C., Xie, J. S., Chang, G. L., & Zhang, D. Y. (2020). TNAP inhibition attenuates cardiac fibrosis induced by myocardial infarction through deactivating TGF-\u03b21\/Smads and activating P53 signaling pathways. Cell Death & Disease, 11, 44.","journal-title":"Cell Death & Disease"},{"key":"10089_CR28","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.carpath.2007.02.007","volume":"16","author":"LL Chen","year":"2007","unstructured":"Chen, L. L., Yin, H., & Huang, J. (2007). Inhibition of TGF-beta1 signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through angiogenesis and reduction of apoptosis. Cardiovascular Pathology, 16, 221\u2013230.","journal-title":"Cardiovascular Pathology"},{"key":"10089_CR29","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1097\/HJH.0b013e328333af48","volume":"28","author":"W Huang","year":"2010","unstructured":"Huang, W., Rubinstein, J., Prieto, A. R., & Wang, D. H. (2010). Enhanced postmyocardial infarction fibrosis via stimulation of the transforming growth factor-beta-Smad2 signaling pathway: role of transient receptor potential vanilloid type 1 channels. Journal of Hypertension, 28, 367\u2013376.","journal-title":"Journal of Hypertension"},{"key":"10089_CR30","doi-asserted-by":"publisher","first-page":"998","DOI":"10.3892\/etm.2016.2969","volume":"11","author":"H Liu","year":"2016","unstructured":"Liu, H., Liu, A., Shi, C., & Li, B. (2016). Curcumin suppresses transforming growth factor-\u03b21-induced cardiac fibroblast differentiation via inhibition of Smad-2 and p38 MAPK signaling pathways. Experimental and Therapeutic Medicine, 11, 998\u20131004.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"10089_CR31","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12872-015-0169-z","volume":"16","author":"H Wu","year":"2016","unstructured":"Wu, H., Li, G. N., Xie, J., Li, R., Chen, Q. H., Chen, J. Z., Wei, Z. H., Kang, L. N., & Xu, B. (2016). Resveratrol ameliorates myocardial fibrosis by inhibiting ROS\/ERK\/TGF-\u03b2\/periostin pathway in STZ-induced diabetic mice. BMC Cardiovascular Disorders, 16, 5.","journal-title":"BMC Cardiovascular Disorders"},{"key":"10089_CR32","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1186\/s13578-019-0348-1","volume":"9","author":"Y Wang","year":"2019","unstructured":"Wang, Y., Guo, Z., Gao, Y., Liang, P., Shan, Y., & He, J. (2019). Angiotensin II receptor blocker LCZ696 attenuates cardiac remodeling through the inhibition of the ERK signaling pathway in mice with pregnancy-associated cardiomyopathy. Cell & Bioscience, 9, 86.","journal-title":"Cell & Bioscience"},{"key":"10089_CR33","doi-asserted-by":"publisher","first-page":"43242","DOI":"10.1038\/srep43242","volume":"7","author":"S Luo","year":"2017","unstructured":"Luo, S., Hieu, T. B., Ma, F., Yu, Y., Cao, Z., Wang, M., Wu, W., Mao, Y., Rose, P., Law, B. Y., & Zhu, Y. Z. (2017). ZYZ-168 alleviates cardiac fibrosis after myocardial infarction through inhibition of ERK1\/2-dependent ROCK1 activation. Scientific Reports, 7, 43242.","journal-title":"Scientific Reports"},{"key":"10089_CR34","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1111\/j.1476-5381.2010.01070.x","volume":"162","author":"Z Pan","year":"2011","unstructured":"Pan, Z., Zhao, W., Zhang, X., Wang, B., Wang, J., Sun, X., Liu, X., Feng, S., Yang, B., & Lu, Y. (2011). Scutellarin alleviates interstitial fibrosis and cardiac dysfunction of infarct rats by inhibiting TGF\u03b21 expression and activation of p38-MAPK and ERK1\/2. British Journal of Pharmacology, 162, 688\u2013700.","journal-title":"British Journal of Pharmacology"}],"container-title":["Journal of Cardiovascular Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12265-020-10089-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12265-020-10089-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,27]],"date-time":"2021-08-27T15:17:55Z","timestamp":1630077475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12265-020-10089-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,6]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["10089"],"URL":"https:\/\/doi.org\/10.1007\/s12265-020-10089-2","relation":{},"ISSN":["1937-5387","1937-5395"],"issn-type":[{"value":"1937-5387","type":"print"},{"value":"1937-5395","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,6]]},"assertion":[{"value":"8 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 November 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All experimental procedures were conducted in compliance with both the Animal Care and Use Committee of Capital Medical University and the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (the 8th Edition, NRC 2011). This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}}]}}